OTCMKTS:KWBT - Kiwa Bio-Tech Products Group Stock Price, News, & Analysis

+0.19 (+31.15 %)
(As of 07/19/2019 04:00 PM ET)
Today's Range
Now: $0.80
50-Day Range
MA: $0.75
52-Week Range
Now: $0.80
Volume400 shs
Average Volume548 shs
Market Capitalization$15.58 million
P/E Ratio15.27
Dividend YieldN/A
Kiwa Bio-Tech Products Group Corporation, through its subsidiaries, develops, manufactures, distributes, and markets bio-technological products for the agricultural market primarily in the People's Republic of China. It offers bacillus species and/or photosynthetic bacteria based biological organic and compound microbial fertilizers. The company has a strategic relationship with ETS (Tianjin) Biological Science and Technology Development Co., Ltd. to produce bio-fertilizers in the People's Republic of China and internationally; and strategic cooperation agreements with the Beijing Zhongpin Agricultural Science and Technology Development Center, as well as China Academy of Agricultural Science's Institute of Agricultural Resources & Regional Planning, and Institute of Agricultural Economy & Development. Kiwa Bio-Tech Products Group Corporation was founded in 2002 and is headquartered in Yangling, China.

Industry, Sector and Symbol

Industry Agricultural chemicals
SectorBasic Materials
Current SymbolOTCMKTS:KWBT



Sales & Book Value

Annual Sales$30.65 million
Cash Flow$0.0289 per share
Book Value$0.75 per share


Net Income$340,000.00


Market Cap$15.58 million
Next Earnings Date8/21/2019 (Estimated)
OptionableNot Optionable

Receive KWBT News and Ratings via Email

Sign-up to receive the latest news and ratings for KWBT and its competitors with MarketBeat's FREE daily newsletter.

Kiwa Bio-Tech Products Group (OTCMKTS:KWBT) Frequently Asked Questions

What is Kiwa Bio-Tech Products Group's stock symbol?

Kiwa Bio-Tech Products Group trades on the OTCMKTS under the ticker symbol "KWBT."

How were Kiwa Bio-Tech Products Group's earnings last quarter?

Kiwa Bio-Tech Products Group Co. (OTCMKTS:KWBT) announced its quarterly earnings data on Wednesday, May, 15th. The company reported $0.02 EPS for the quarter. The business had revenue of $9.54 million for the quarter. Kiwa Bio-Tech Products Group had a net margin of 2.17% and a return on equity of 5.19%. View Kiwa Bio-Tech Products Group's Earnings History.

When is Kiwa Bio-Tech Products Group's next earnings date?

Kiwa Bio-Tech Products Group is scheduled to release their next quarterly earnings announcement on Wednesday, August 21st 2019. View Earnings Estimates for Kiwa Bio-Tech Products Group.

Has Kiwa Bio-Tech Products Group been receiving favorable news coverage?

Media headlines about KWBT stock have been trending somewhat positive recently, according to InfoTrie Sentiment. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Kiwa Bio-Tech Products Group earned a media sentiment score of 2.0 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the next few days. View News Stories for Kiwa Bio-Tech Products Group.

Who are some of Kiwa Bio-Tech Products Group's key competitors?

What other stocks do shareholders of Kiwa Bio-Tech Products Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Kiwa Bio-Tech Products Group investors own include Aurora Cannabis (ACB), Beacon Roofing Supply (BECN), eGain (EGAN), INTL Fcstone (INTL), Marlin Business Services (MRLN), Playa Hotels & Resorts (PLYA), QUALCOMM (QCOM), Zynga (ZNGA), BorgWarner (BWA) and HCA Healthcare (HCA).

Who are Kiwa Bio-Tech Products Group's key executives?

Kiwa Bio-Tech Products Group's management team includes the folowing people:
  • Ms. Siuhung Wang-Liu, Chairman, Acting CEO & Acting Pres (Age 41)
  • Mr. Hon Man Yun, Chief Financial Officer (Age 50)
  • Mr. Xiao Qiang Yu, Chief Operating Officer (Age 41)
  • Mr. Yong Lin Song, CTO, Director of Technology & Director (Age 52)
  • Prof. Qi Wang, VP of Technology & Director (Age 53)

How do I buy shares of Kiwa Bio-Tech Products Group?

Shares of KWBT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Kiwa Bio-Tech Products Group's stock price today?

One share of KWBT stock can currently be purchased for approximately $0.80.

How big of a company is Kiwa Bio-Tech Products Group?

Kiwa Bio-Tech Products Group has a market capitalization of $15.58 million and generates $30.65 million in revenue each year. Kiwa Bio-Tech Products Group employs 63 workers across the globe.View Additional Information About Kiwa Bio-Tech Products Group.

What is Kiwa Bio-Tech Products Group's official website?

The official website for Kiwa Bio-Tech Products Group is http://www.kiwabiotech.com/.

How can I contact Kiwa Bio-Tech Products Group?

Kiwa Bio-Tech Products Group's mailing address is 3200 Guasti Road Suite #100, Ontario CA, 91761. The company can be reached via phone at 909-456-8828 or via email at [email protected]

MarketBeat Community Rating for Kiwa Bio-Tech Products Group (OTCMKTS KWBT)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  53 (Thanks for Voting!)
Underperform Votes:  52 (Thanks for Voting!)
Total Votes:  105
MarketBeat's community ratings are surveys of what our community members think about Kiwa Bio-Tech Products Group and other stocks. Vote "Outperform" if you believe KWBT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe KWBT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/19/2019 by MarketBeat.com Staff

Featured Article: Strangles

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel